AgResearch scientists are working with commercial drug companies to develop genetically modified medicines, considering breast cancer drug Hercepton, Interferon, which slows the onset of multiple sclerosis, and human lactoferrin. The company’s applied biotechnologies manager, Jimmy Suttie, said AgResearch had been involved in genetic modification (GM) technology for eight years and viewed biopharming, or the production of pharmaceutical proteins in milk, as a suitable application given widely-used drugs were coming off patent in the next three years.